RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION
Aim. To assess effectiveness and safety of the hospital use of recombinant non-immunogenic staphylokinase in patients with acute ST-elevated myocardial infarction (STEMI).Material and methods. Recombinant non-immunogenic staphylokinase was administered during in-hospital stage of treatment of 93 pa...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Столичная издательская компания
2017-03-01
|
| シリーズ: | Рациональная фармакотерапия в кардиологии |
| 主題: | |
| オンライン･アクセス: | https://www.rpcardio.online/jour/article/view/1416 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|